Patents by Inventor Vijaykant PANDEY

Vijaykant PANDEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Lyophilized pharmaceutical composition of Fc-peptide fusion protein
    Patent number: 10918698
    Abstract: A novel and thermostable lyophilized pharmaceutical composition of Romiplostim (Fcpeptide fusion protein) along with buffer, bulking agent, stabilizer, and surfactant at pH range of 4.0-6.0.
    Type: Grant
    Filed: March 24, 2015
    Date of Patent: February 16, 2021
    Assignee: INTAS PHARMACEUTICALS LTD.
    Inventors: Himanshu Gadgil, Chandresh Chhatbar, Vijaykant Pandey
  • LIQUID PHARMACEUTICAL COMPOSITION OF ADALIMUMAB
    Publication number: 20200405864
    Abstract: The present invention relates to a liquid pharmaceutical composition comprising an anti-TNF? antibody, buffer, stabilizer, and surfactant.
    Type: Application
    Filed: June 5, 2020
    Publication date: December 31, 2020
    Applicant: INTAS PHARMACEUTICALS LTD.
    Inventors: Himanshu GADGIL, Chandresh CHHATBAR, Vijaykant PANDEY
  • Liquid pharmaceutical composition of adalimumab
    Patent number: 10688187
    Abstract: A liquid pharmaceutical composition having an anti-TNF? antibody, a buffer, a stabilizer, and a surfactant.
    Type: Grant
    Filed: February 18, 2015
    Date of Patent: June 23, 2020
    Assignee: INTAS PHARMACEUTICALS LTD.
    Inventors: Himanshu Gadgil, Chandresh Chhatbar, Vijaykant Pandey
  • Liquid pharmaceutical composition of conjugated erythropoietin
    Patent number: 10052361
    Abstract: A liquid pharmaceutical composition having a conjugated erythropoietin, buffer, sugar, tonicity modifier and amino acid as an aggregation inhibitor. The liquid pharmaceutical composition provides a stable pharmaceutical composition which encompasses conjugated erythropoietin, acetate buffer, sucrose, arginine and sodium chloride which is maintained at a pH of about 4.9 to 5.3.
    Type: Grant
    Filed: February 27, 2015
    Date of Patent: August 21, 2018
    Assignee: INTAS PHARMACEUTICALS LTD
    Inventors: Chandresh Chhatbar, Vijaykant Pandey, Nildip Chauhan
  • LYOPHILIZED PHARMACEUTICAL COMPOSITION OF FC-PEPTIDE FUSION PROTEIN
    Publication number: 20170112903
    Abstract: A novel and thermostable lyophilized pharmaceutical composition of Romiplostim (Fcpeptide fusion protein) along with buffer, bulking agent, stabilizer, and surfactant at pH range of 4.0-6.0.
    Type: Application
    Filed: March 24, 2015
    Publication date: April 27, 2017
    Applicant: INTAS PHARMACEUTICALS LTD.
    Inventors: Himanshu GADGIL, Chandresh CHHATBAR, Vijaykant PANDEY
  • LIQUID PHARMACEUTICAL COMPOSITION OF CONJUGATED ERYTHROPOIETIN
    Publication number: 20170112901
    Abstract: A liquid pharmaceutical composition having a conjugated erythropoietin, buffer, sugar, tonicity modifier and amino acid as an aggregation inhibitor. The liquid pharmaceutical composition provides a stable pharmaceutical composition which encompasses conjugated erythropoietin, acetate buffer, sucrose, arginine and sodium chloride which is maintained at a pH of about 4.9 to 5.3.
    Type: Application
    Filed: February 27, 2015
    Publication date: April 27, 2017
    Applicant: INTAS PHARMACEUTICALS LTD.
    Inventors: Chandresh CHHATBAR, Vijaykant PANDEY, Nildip CHAUHAN
  • LIQUID PHARMACEUTICAL COMPOSITION OF ADALIMUMAB
    Publication number: 20170106090
    Abstract: A liquid pharmaceutical composition having an anti-TNF? antibody, a buffer, a stabilizer, and a surfactant.
    Type: Application
    Filed: February 18, 2015
    Publication date: April 20, 2017
    Applicant: INTAS PHARMACEUTICALS LTD.
    Inventors: Himanshu GADGIL, Chandresh CHHATBAR, Vijaykant PANDEY